Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT00116597
First received: June 29, 2005
Last updated: December 1, 2009
Last verified: December 2009